brigatinib
Description: Brigatinib is an anticancer drug that inhibits anaplastic lymphoma kinase and is used to treat certain forms of non-small cell lung cancer.
Primary topic: Lung Cancer Treatments and Mutations (72%)
Related topic: Lung Cancer Treatments and Mutations (72%)
Wikidata ID: wiki/Q27456393
OpenAlex ID: keywords/brigatinib
